PET-guided Radiotherapy for Patients With Small Cell Lung Cancer.
ConditionSmall Cell Lung Carcinoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Essen
About this trial
There is a prospective risk-adapted evaluation of the optimal dose of radiotherapy for definitive radiotherapy of locally advanced small cell lung cancer within the corridor recommended as standard therapy according to the current interdisciplinary S3 guideline of the German Cancer Society/Cancer Aid/AWMF
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Histopathologic confirmation
Limited disease
Disqualifiers
Other histology than small cell lung cancer
Further tumor diagnosis
ECOG 3 or worse
Extensive disease
Trial population
Patients with confirmed diagnosis of small cell lung cancer
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
PET based Raditherapy boost
RadiationAn Interim PET CT will be performed. If there is residual vital tumor, a higher radiation dose will be applied.
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Local recurrence free survival
Local recurrence free survival
Time frame
2 months to 5 years2
Distant recurrence free survival
Distant recurrence free survival
Time frame
2 months to 5 years3
Overall survival
Overall survival
Time frame
2 months to 5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov